Skip to content
10-Q

Quarterly Report

PHIBRO ANIMAL HEALTH CORP PAHC

0001558370-25-000659

← back to feed
Filed
Feb 5, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Long Term Debt Q2 2025 · Dec 31, 2024 $622.88M
Long Term Debt Q2 2025 · Jun 30, 2024 $282.29M
Short Term Investments Q2 2025 · Dec 31, 2024 $0
Short Term Investments Q2 2025 · Jun 30, 2024 $44M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $67.07M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $70.61M
Stockholders Equity Q2 2025 · Dec 31, 2024 $246.8M
Stockholders Equity Q2 2025 · Jun 30, 2024 $256.64M
Current Liabilities Q2 2025 · Dec 31, 2024 $233.25M
Current Liabilities Q2 2025 · Jun 30, 2024 $204.15M
Total Liabilities Q2 2025 · Dec 31, 2024 $1.04B
Total Liabilities Q2 2025 · Jun 30, 2024 $725.54M
Current Assets Q2 2025 · Dec 31, 2024 $746.15M
Current Assets Q2 2025 · Jun 30, 2024 $601M
Total Assets Q2 2025 · Dec 31, 2024 $1.29B
Total Assets Q2 2025 · Jun 30, 2024 $982.18M
Shares Diluted Q2 2025 · Dec 31, 2023 40.5M sh
Shares Diluted Q2 2025 · Dec 31, 2023 40.5M sh
Dividends Paid Q2 2025 · Dec 31, 2023 $9.72M
Capex Q2 2025 · Dec 31, 2023 $18.44M
Operating Cash Flow Q2 2025 · Dec 31, 2023 $47.76M
Eps Diluted Q2 2025 · Dec 31, 2023 $0.03
Eps Diluted Q2 2025 · Dec 31, 2023 −$0.17
Eps Basic Q2 2025 · Dec 31, 2023 $0.03
Eps Basic Q2 2025 · Dec 31, 2023 −$0.17
Sga Expense Q2 2025 · Dec 31, 2023 $62.92M
Sga Expense Q2 2025 · Dec 31, 2023 $131.37M
Net Income Q2 2025 · Dec 31, 2023 $1.27M
Net Income Q2 2025 · Dec 31, 2023 −$6.74M
Operating Income Q2 2025 · Dec 31, 2023 $15.7M
Operating Income Q2 2025 · Dec 31, 2023 $14.98M
Gross Profit Q2 2025 · Dec 31, 2023 $78.62M
Gross Profit Q2 2025 · Dec 31, 2023 $146.34M
Cost Of Revenue Q2 2025 · Dec 31, 2023 $171.33M
Cost Of Revenue Q2 2025 · Dec 31, 2023 $334.95M
Revenue Q2 2025 · Dec 31, 2023 $249.94M
Revenue Q2 2025 · Dec 31, 2023 $481.29M